YM-14673, a thyrotropin-releasing hormone analogue, injected into the nucleus accumbens and the striatum produces repetitive jaw movements in rats.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  European Journal of Pharmacology

• Publication date

  1995-04-13

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0014-2999(95)00066-TPMID 7635174
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Induction of oral stereotypy following amphetamine microinjection into a discrete subregion of the striatum

  2004cited by this paper
• Cholinergic stimulation of the ventrolateral striatum elicits mouth movements in rats: pharmacological and regional specificity

  2004cited by this paper
• Ataxia-ameliorating effects of YM-14673, a potent analog of thyrotropin releasing hormone, in ataxic mutant mice.

  1994cited by this paper
• Clozapine injected into the nucleus accumbens potentiates apomorphine-induced jaw movements.

  1994cited by this paper
• Involvement of the nucleus accumbens in oral behaviour in the freely moving rat.

  1993cited by this paper
• Assessment of the role of TRH in the release of [3H]-dopamine from rat nucleus accumbens-lateral septum slices.

  1993cited by this paper
• Jaw muscle activity, the nucleus accumbens, and dopaminergic agonists: a new approach.

  1992cited by this paper
• Cholinergic/dopaminergic interaction in the rat striatum assessed from drug-induced repetitive oral movements.

  1992cited by this paper
• Interactions between dopamine D1 and D2 receptors in the model of thyrotropin-releasing hormone (TRH)-induced behaviour in rabbits.

  1991cited by this paper
• Functional interaction between dopamine D1 and D2 receptors in rat jaw movements.

  1991cited by this paper
• Peptidergic Regulation of Striatal Dopamine Transporter Complex

  1991cited by this paper
• In vivo striatal dopamine release by TRH analog YM-14673 is blocked by M1 muscarinic receptor antagonist.

  1990cited by this paper
• Dopamine D-1 but not D-2 receptor stimulation of the dorsal striatum potentiates apomorphine-induced jaw movements in rats.

  1990cited by this paper
• Central dopaminergic actions of YM-14673, a new TRH analogue, in rodents.

  1990cited by this paper
• Effects of dopamine D1 and D2 agonists and antagonists injected into the nucleus accumbens and globus pallidus on jaw movements of rats.

  1990cited by this paper
• The role of D1 and D2 dopamine receptors in oral stereotypy induced by dopaminergic stimulation of the ventrolateral striatum.

  1990cited by this paper
• Effects of a new analogue of thyrotropin-releasing hormone on pentobarbital-induced sleeping time in rodents.

  1989cited by this paper
• Involvement of 5‐HT2 receptors in the behaviours produced by intrathecal administration of selected 5‐HT agonists and the TRH analogue (CG 3509) to rats

  1989cited by this paper
• Effects of intrastriatal injections of selective dopamine D-1 and D-2 agonists and antagonists on jaw movements of rats.

  1989cited by this paper
• Enhanced behavioral stereotypies elicited by intrastriatal injection of D1 and D2 dopamine agonists in intact rats

  1989cited by this paper
• Stereotypies elicited by injection of N-propylnorapomorphine into striatal subregions and nucleus accumbens.

  1989cited by this paper
• Comparative behavioural and biochemical effects of repeated intrathecal administration of thyrotrophin-releasing hormone (TRH) or two analogues of TRH in adult rats.

  1989cited by this paper
• Effects of a new TRH analogue, YM-14673 on a passive avoidance test as a possible criterion of improvement in cognitive disturbance in rodents

  1988cited by this paper
• In vitro studies with ICI 169,369, a chemically novel 5-HT antagonist.

  1988cited by this paper
• Sulpiride injection into the dorsal striatum increases methamphetamine-induced gnawing in rats.

  1987cited by this paper
• Effect of TRH analog (DN-1417) on tyrosine hydroxylase activity in mesocortical, mesolimbic and nigrostriatal dopaminergic neurons of rat brain.

  1987cited by this paper
• Effects of a new TRH analogue, YM-14673 on the central nervous system

  1987cited by this paper
• The Rat Brain in Stereotaxic Coordinates

  1983cited by this paper
• Species Differences in the Brain Regional Distribution of Receptor Binding for Thyrotropin‐Releasing Hormone

  1982cited by this paper
• Thyrotropin-releasing hormone.

  1982cited by this paper
• Thyrotrophin‐Releasing Hormone Analogues Increase Dopamine Release from Slices of Rat Brain

  1982cited by this paper
• Pharmacological properties of new antipsychotic agents: use of animal models.

  1981cited by this paper
• γ-butyrolactone-γ-carbonyl-histidyl-prolinamide citrate (DN-1417) : A novel TRH analog with potent effects on the central nervous system

  1981cited by this paper
• Gamma-butyrolactone-gamma-carbonyl-histidyl-prolinamide citrate (DN-1417): a novel TRH analog with potent effects on the central nervous system.

  1981cited by this paper
• Enzymic formation of TRH-OH from TRH by rat hypothalamus.

  1980cited by this paper
• Chronic catheterization of the spinal subarachnoid space.

  1976cited by this paper
• Thyrotropin Releasing Hormone: Enhancement of Dopa Activity by a Hypothalamic Hormone

  1972cited by this paper

• TRH Analog, Taltirelin Improves Motor Function of Hemi-PD Rats Without Inducing Dyskinesia via Sustained Dopamine Stimulating Effect

  2018cites this paper
• Behavioral pharmacology of orofacial movement disorders.

  2011cites this paper
• Levodopa-Induced Dyskinesia Is Associated with Increased Thyrotropin Releasing Hormone in the Dorsal Striatum of Hemi-Parkinsonian Rats

  2010cites this paper
• Discovery of a dual action first-in-class peptide that mimics and enhances CNS-mediated actions of thyrotropin-releasing hormone.

  2007cites this paper
• Central nervous system effects of thyrotropin-releasing hormone and its analogues: opportunities and perspectives for drug discovery and development.

  2002cites this paper
• Neurotoxicity associated with neuroleptic-induced oral dyskinesias in rats. Implications for tardive dyskinesia?

  2000cites this paper
• Effects of YM-14673, a thyrotropin-releasing hormone analogue, injected into the shell and the core of the nucleus accumbens on production of repetitive jaw movements in rats: comparison with the effects of a dopamine D1 and D2 receptor agonist combination.

  1997cites this paper
• MIT Open Access

  year unknowncites this paper